Literature DB >> 9474399

Glenoid rim lesions associated with recurrent anterior dislocation of the shoulder.

L U Bigliani1, P M Newton, S P Steinmann, P M Connor, S J Mcllveen.   

Abstract

Twenty-five shoulders with recurrent instability and associated anterior glenoid rim lesions were reviewed to 1) develop a classification system of the lesions, 2) evaluate radiographic techniques in detecting the lesions, and 3) analyze the outcome of surgery. Lesions were classified into three types: Type I, a displaced avulsion fracture with attached capsule; Type II, a medially displaced fragment malunited to the glenoid rim; and Type III, erosion of the glenoid rim with less than 25% (Type IIIA) or greater than 25% (Type IIIB) deficiency. Lesions were detected by plain radiographs (19 shoulders) or supplemental CT-arthrograms (12 shoulders) or both. In 16 Type I fractures, both the bony fragment and capsule were reattached to the glenoid rim. In five Type II and three Type IIIA lesions, only the capsule was repaired to the remaining glenoid rim. In the one Type IIIB lesion, a coracoid transfer was performed. At an average followup of 30 months, 22 shoulders (88%) had satisfactory results without recurrent instability, whereas three shoulders (12%) had postoperative redislocations. The majority of recurrent anterior dislocations with associated glenoid rim lesions can be treated by suturing the fracture fragment or capsule or both to the glenoid rim and addressing associated capsular laxity.

Entities:  

Mesh:

Year:  1998        PMID: 9474399     DOI: 10.1177/03635465980260012301

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  117 in total

1.  [Shoulder instability. Classification and treatment].

Authors:  P Habermeyer; P Magosch; S Lichtenberg
Journal:  Orthopade       Date:  2004-07       Impact factor: 1.087

2.  History of shoulder instability surgery.

Authors:  Pietro Randelli; Davide Cucchi; Usman Butt
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-12-19       Impact factor: 4.342

3.  Lateral Decubitus All-Arthroscopic Latarjet Procedure for Treatment of Shoulder Instability.

Authors:  Matthew R Lewington; Nathan Urquhart; Ivan H Wong
Journal:  Arthrosc Tech       Date:  2015-05-11

4.  Biomechanical comparison of the Latarjet procedure with and without a coracoid bone block.

Authors:  W Barrett Payne; Matthew T Kleiner; Michelle H McGarry; James E Tibone; Thay Q Lee
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-12-12       Impact factor: 4.342

5.  Case series: Combined large Hill-Sachs and bony Bankart lesions treated by Latarjet and partial humeral head resurfacing: a report of 2 cases.

Authors:  Philippe Grondin; Jordan Leith
Journal:  Can J Surg       Date:  2009-06       Impact factor: 2.089

6.  A simple method for quantitative evaluation of the missing area of the anterior glenoid in anterior instability of the glenohumeral joint.

Authors:  Vidal S Barchilon; Eugene Kotz; Mercedes Barchilon Ben-Av; Ernesto Glazer; Meir Nyska
Journal:  Skeletal Radiol       Date:  2008-06-04       Impact factor: 2.199

7.  Arthroscopic three-point double-row repair for acute bony Bankart lesions.

Authors:  Kyung Cheon Kim; Kwang Jin Rhee; Hyun Dae Shin
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2008-11-08       Impact factor: 4.342

8.  [Bony Bankart lesions].

Authors:  U J Spiegl; S Braun; S A Euler; R J Warth; P J Millett
Journal:  Unfallchirurg       Date:  2014-12       Impact factor: 1.000

9.  Recurrent anterior glenohumeral instability: the quantification of glenoid bone loss using magnetic resonance imaging.

Authors:  Patrícia Martins e Souza; Bruno Lobo Brandão; Eduardo Brown; Geraldo Motta; Martim Monteiro; Edson Marchiori
Journal:  Skeletal Radiol       Date:  2014-05-08       Impact factor: 2.199

10.  Arthroscopic treatment of glenoid bone loss.

Authors:  Ettore Taverna; Guido Garavaglia; Henri Ufenast; Riccardo D'Ambrosi
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-12-12       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.